search
Back to results

Open Versus Laparoscopic Complete Mesocolic Excision for Locally Advanced Colon Cancer (OLCMECC)

Primary Purpose

Colon Cancer

Status
Unknown status
Phase
Phase 3
Locations
China
Study Type
Interventional
Intervention
Open surgery
Laparoscopic surgery
Sponsored by
The First Affiliated Hospital with Nanjing Medical University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Colon Cancer focused on measuring Complete Mesocolic Excision, locally advanced Colon Cancer, Laparoscopic

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients suitable for curative surgery over 18 years old;
  • American Society of Anesthesiologists(ASA) grade I-III;
  • Pathological diagnosis of adenocarcinoma;
  • Tumor located between the cecum and sigmoid colon;
  • Enhanced CT scan of chest, abdominal and pelvic cavity: preoperative assessment of tumor stage is T3-T4 N0 or T any N+ (according to the National Comprehensive Cancer Network(NCCN) clinical practice guidelines in oncology: colon cancer version 2.2015);there is no distant metastasis;
  • Informed consent;
  • No preoperative chemoradiotherapy;
  • No history of familial adenomatous polyposis, ulcerative colitis or Crohn's disease.

Exclusion Criteria:

  • Pregnant patient;
  • History of psychiatric disease;
  • Use of systemic steroids;
  • Conversion to laparotomy;
  • Simultaneous or simultaneous multiple primary colorectal cancer;
  • Preoperative imaging examination results show:

    1. Tumor involves the surrounding organs and combined organ resection need to be done;
    2. distant metastasis;
    3. unable to perform R0 resection;
  • Postoperative pathology of T1-T2 N0;
  • History of any other malignant tumor in recent 5 years;
  • Patients need emergency operation: mechanic ileus, perforation.
  • Not suitable for laparoscopic surgery (i.e., extensive adhesion caused by abdominal surgery, not suitable for artificial pneumoperitoneum, etc).

Sites / Locations

  • Jiangsu province hospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Open surgery

Laparoscopic surgery

Arm Description

Patients undergo open CME. A standard midline incision carefully protected is made through the abdominal wall and the abdominal cavity is explored. A colectomy with CME is performed with the removal of the afflicted colon and its accessory lymphovascular supply at their origins by resecting the colon and mesocolon in an intact envelope of visceral peritoneum and mesenteric fascia.

Patients undergo laparoscopic CME. A small infraumbilical incision is made through the abdominal skin and the abdominal cavity is insufflated with carbon dioxide to allow access and visualization. The abdominal cavity is explored. A colectomy with CME is performed using laparoscopic-assisted techniques. A 6-8cm midline auxiliary incision is made for specimen extraction and anastomosis.

Outcomes

Primary Outcome Measures

disease-free survival

Secondary Outcome Measures

overall survival
recurrence-free survival
local recurrence rate
length of postoperative hospital stay
Length of postoperative hospital stay is defined as a duration between surgery and first discharge. An expected average is 10 days.
early complication rate
Early complication is defined as a complication that occurred between the finish of the surgery and postoperative day 30. Complications includes anastomotic leakage, anastomotic bleeding, chyle leakage, wound infection, pulmonary embolism, myocardial infarction et al.The Clavien-Dindo Classification of Surgical Complications will be applied to access the degree of severity of postoperative complications.
operative time
completeness of the mesocolon of the specimen
A central review by pathologists to define the completeness of the mesocolon to be good, moderate or poor will be performed on the specimen photographs.
number of lymph nodes retrieved
postoperative quality of life as assessed by EORTC QLQ-C30 questionnaire
Compare the differences in postoperative quality of life of patients treated with these two regimens using EORTC QLQ-C30 questionnaire

Full Information

First Posted
February 4, 2016
Last Updated
July 3, 2016
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Collaborators
West China Hospital, Changhai Hospital, Chinese PLA General Hospital, Peking Union Medical College Hospital, Ruijin Hospital, RenJi Hospital, Shanghai Changzheng Hospital, Wuhan Union Hospital, China, Fujian Medical University, First Affiliated Hospital of Chongqing Medical University
search

1. Study Identification

Unique Protocol Identification Number
NCT02682589
Brief Title
Open Versus Laparoscopic Complete Mesocolic Excision for Locally Advanced Colon Cancer
Acronym
OLCMECC
Official Title
A Multicenter, Prospective, Randomized Clinical Trial to Investigate Open Versus Laparoscopic Complete Mesocolic Excision for Locally Advanced Colon Cancer
Study Type
Interventional

2. Study Status

Record Verification Date
July 2016
Overall Recruitment Status
Unknown status
Study Start Date
April 2016 (undefined)
Primary Completion Date
April 2023 (Anticipated)
Study Completion Date
April 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The First Affiliated Hospital with Nanjing Medical University
Collaborators
West China Hospital, Changhai Hospital, Chinese PLA General Hospital, Peking Union Medical College Hospital, Ruijin Hospital, RenJi Hospital, Shanghai Changzheng Hospital, Wuhan Union Hospital, China, Fujian Medical University, First Affiliated Hospital of Chongqing Medical University

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Randomized, multicenter, phase III trial to compare the short and long outcomes of laparoscopic CME with open CME in treating patients with locally advanced colon cancer.
Detailed Description
Laparoscopic complete mesocolic excision (CME) in treating colon cancer has been reported to be feasible and safe and holds many advantages when compared with traditional open surgery, such as reducing preoperative blood loss, alleviating postoperative pain and reducing complications and length of hospital stay. Whether laparoscopic CME could achieve an equivalent oncological outcome, especially for locally advanced malignancy, is still being discussed. The purpose of this study is to determine the short and long outcomes of open and laparoscopic CME for locally advanced colon cancer patients. The primary endpoint is the 5-year disease-free survival rate. Secondary endpoints include completeness of mesocolon, morbidity and mortality, local recurrence, overall survival, quality of life et al. In this study, eligible patient will be randomly allocated to receive either open or laparoscopic CME surgery. Randomization will be performed centrally and be stratified for age, gender, T-stage, tumor location. Patients will be randomized in a 2:1 ratio, in favor of the laparoscopic CME. The extent of resection according to CME principle is identical for both arms. CME involves the removal of the afflicted colon and its accessory lymphvascular supply at their origins by resecting the colon and mesocolon in an intact envelope of visceral peritoneum and mesenteric fascia. Type of anastomosis, location of auxiliary incision and drainage of surgical field are up to the discretion of the surgeon. In laparoscopic surgery, a "medial-to-lateral" approach and a no-touch isolation are required . Intraoperative pictures were taken at various stages, as were photographs of the postoperative specimen, which will be assessed by a third-party expert to qualify the surgery. The baseline demographics and conditions as well as the perioperative and postoperative outcomes will be recorded through a prior designed format. Our study is expected to last seven years, of which two years for recruiting patients, five years for follow-up. Patients are followed up every 3 months for 2 year, every 6 months for 3 years postoperatively.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Colon Cancer
Keywords
Complete Mesocolic Excision, locally advanced Colon Cancer, Laparoscopic

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
1080 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Open surgery
Arm Type
Active Comparator
Arm Description
Patients undergo open CME. A standard midline incision carefully protected is made through the abdominal wall and the abdominal cavity is explored. A colectomy with CME is performed with the removal of the afflicted colon and its accessory lymphovascular supply at their origins by resecting the colon and mesocolon in an intact envelope of visceral peritoneum and mesenteric fascia.
Arm Title
Laparoscopic surgery
Arm Type
Experimental
Arm Description
Patients undergo laparoscopic CME. A small infraumbilical incision is made through the abdominal skin and the abdominal cavity is insufflated with carbon dioxide to allow access and visualization. The abdominal cavity is explored. A colectomy with CME is performed using laparoscopic-assisted techniques. A 6-8cm midline auxiliary incision is made for specimen extraction and anastomosis.
Intervention Type
Procedure
Intervention Name(s)
Open surgery
Intervention Description
A traditional midline incision is made through the abdominal wall and a colectomy with CME is performed.
Intervention Type
Procedure
Intervention Name(s)
Laparoscopic surgery
Intervention Description
3-5 small incisions are made through the abdominal wall for the placement of trocars and the abdominal cavity is insufflated with carbon dioxide to allow access, visualization and operation. A 6-8cm auxiliary incision is made for specimen extraction and anastomosis. Conversion may occur due to technical difficulties or intraoperative complications, which is defined when completion of the dissection of the mesocolon is performed through a traditional open abdominal approach. Patients undergo conversion to laparotomy will be excluded from this study.
Primary Outcome Measure Information:
Title
disease-free survival
Time Frame
5 years
Secondary Outcome Measure Information:
Title
overall survival
Time Frame
5 years
Title
recurrence-free survival
Time Frame
5 years
Title
local recurrence rate
Time Frame
5 years
Title
length of postoperative hospital stay
Description
Length of postoperative hospital stay is defined as a duration between surgery and first discharge. An expected average is 10 days.
Time Frame
30 days
Title
early complication rate
Description
Early complication is defined as a complication that occurred between the finish of the surgery and postoperative day 30. Complications includes anastomotic leakage, anastomotic bleeding, chyle leakage, wound infection, pulmonary embolism, myocardial infarction et al.The Clavien-Dindo Classification of Surgical Complications will be applied to access the degree of severity of postoperative complications.
Time Frame
30 days
Title
operative time
Time Frame
1 day
Title
completeness of the mesocolon of the specimen
Description
A central review by pathologists to define the completeness of the mesocolon to be good, moderate or poor will be performed on the specimen photographs.
Time Frame
1 day
Title
number of lymph nodes retrieved
Time Frame
1 day
Title
postoperative quality of life as assessed by EORTC QLQ-C30 questionnaire
Description
Compare the differences in postoperative quality of life of patients treated with these two regimens using EORTC QLQ-C30 questionnaire
Time Frame
5 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients suitable for curative surgery over 18 years old; American Society of Anesthesiologists(ASA) grade I-III; Pathological diagnosis of adenocarcinoma; Tumor located between the cecum and sigmoid colon; Enhanced CT scan of chest, abdominal and pelvic cavity: preoperative assessment of tumor stage is T3-T4 N0 or T any N+ (according to the National Comprehensive Cancer Network(NCCN) clinical practice guidelines in oncology: colon cancer version 2.2015);there is no distant metastasis; Informed consent; No preoperative chemoradiotherapy; No history of familial adenomatous polyposis, ulcerative colitis or Crohn's disease. Exclusion Criteria: Pregnant patient; History of psychiatric disease; Use of systemic steroids; Conversion to laparotomy; Simultaneous or simultaneous multiple primary colorectal cancer; Preoperative imaging examination results show: Tumor involves the surrounding organs and combined organ resection need to be done; distant metastasis; unable to perform R0 resection; Postoperative pathology of T1-T2 N0; History of any other malignant tumor in recent 5 years; Patients need emergency operation: mechanic ileus, perforation. Not suitable for laparoscopic surgery (i.e., extensive adhesion caused by abdominal surgery, not suitable for artificial pneumoperitoneum, etc).
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Yueming Sun, PhD
Phone
02568136026
Email
jssym@vip.sina.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Fumin Zhang, Professor
Organizational Affiliation
Ethics Committee of the First Affiliated Hospital, Nanjing Medical University, Jiangsu Province Hospital
Official's Role
Study Director
Facility Information:
Facility Name
Jiangsu province hospital
City
Nanjing
State/Province
Jiangsu
ZIP/Postal Code
210029
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yueming Sun
Phone
68136026
Email
jssym@vip.sina.com

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Open Versus Laparoscopic Complete Mesocolic Excision for Locally Advanced Colon Cancer

We'll reach out to this number within 24 hrs